glp-1 is what Receptor Agonists and Other Drugs GLP-1 Agonists - What is
Description
Nagashima M, Watanabe T, Terasaki M, et al
They called for more research into the possible carcinogenic qualities of GLP-1 drugs
With Mounjaro, it was 4.9%
RECAP study group, Tsukamoto S, Kobayashi K, et al
M., Obesity and Adverse Breast Cancer Risk and Outcome: Mechanistic Insights and Strategies for Intervention, CA: A Cancer Journal for Clinicians 67 (2017): 378397
